Thursday, October 8, 2026
8:00 AM - 12:00 PM

Pre-Conference Workshop: State-of-the-Art Technologies to Advance the Next Generation of FTD Researchers - Track A: “An Introduction to FTD” (Separate Registration Required)
8:00 AM - 8:25 AM
Behavioral Variant Frontotemporal Dementia
Speaker: Olivier Piguet (Australia)
Moderator: Corey McMillan (USA)
8:25 AM - 8:50 AM
Primary Progressive Aphasia
Speaker: Marsel Mesulam (USA)
Moderator: Corey McMillan (USA)
8:50 AM - 9:15 AM
Progressive Supranuclear Palsy and Corticobasal Syndrome
Speaker: James Rowe (UK)
Moderator: Corey McMillan (USA)
9:15 AM - 9:40 AM
ALS-FTD
Speaker: Michael Strong (Canada)
Moderator: Corey McMillan (USA)
9:40 AM - 10:00 AM
Clinical Outcome Measures for FTD Trials
Speaker: Howie Rosen (USA)
Moderator: Corey McMillan (USA)
10:00 AM - 10:15 AM
Coffee Break
10:15 AM - 10:40 AM
Genetics of FTD
Speaker: Vivianna Van Deerlin (USA)
Moderator: David Irwin (USA)
10:40 AM - 11:05 AM
FTLD-TDP and FTLD-FET
Speaker: Manuela Neumann (Germany)
Moderator: David Irwin (USA)
11:05 AM - 11:30 AM
FTLD-Tau
Speaker: Dennis Dickson (USA)
Moderator: David Irwin (USA)
11:30 AM - 12:00 PM
Interactive Digital Pathology Session: Review of Digital Images of Exemplar FTLD Pathology with Audience Participation
Moderator: David Irwin (USA)
8:00 AM - 12:00 PM

Pre-Conference Workshop: State-of-the-Art Technologies to Advance the Next Generation of FTD Researchers - Track B: “Advanced Techniques in FTD Research” (Separate Registration Required)
8:00 AM - 8:25 AM
Spatial-Omics From Postmortem Tissue in ALS-FTD
Speaker: Hemali Phatnani (USA)
Moderator: David Irwin (USA)
8:25 AM - 8:50 AM
Cryo-EM Approaches to Study Protein Aggregates
Speaker: Edward Lee (USA)
Moderator: David Irwin (USA)
8:50 AM - 9:15 AM
Open-Source Digital Pathology
Speaker: Paul Yushkevich (USA)
Moderator: David Irwin (USA)
9:15 AM - 10:00 AM
Hands-on Digital Pathology Session: Interactive Digital Pathology Demonstration of Image Thresholding, Segmentation and Object Detection
Speaker: Daniel Ohm (USA)
Moderator: David Irwin (USA)
10:00 AM - 10:15 AM
Coffee Break
10:15 AM - 10:40 AM
Strategies for Identifying Prodromal Behavior & Cognition in Genetic FTD & ALS
Speaker: Ted Huey (USA)
Moderator: Corey McMillan (USA)
10:40 AM - 11:05 AM
Computational Analysis of Digital Speech Samples in PPA
Speaker: Bradford Dickerson (USA)
Moderator: Corey McMillan (USA)
11:05 AM - 11:30 AM
Digital Metrics of Connected Speech
Speaker: Jet Vonk (USA)
Moderator: Corey McMillan (USA)
11:30 AM - 12:00 PM
Informatic Approaches to Big Data
Speaker: Adam Staffaroni (USA)
Moderator: Corey McMillan (USA)
1:00 PM - 1:15 PM

Opening Ceremony
1:15 PM - 1:30 PM

A Historic Neuropathological Perspective of FTD
Speaker: Virginia Lee
1:30 PM - 1:45 PM

Presidential Lecture
Speaker: Olivier Piguet (Australia)
1:45 PM - 3:15 PM

Plenary Session 1 - Update on Clinical Syndromes
1:45 PM - 2:15 PM
Right Temporal Variant FTD
Speaker: Hulya Ulugut (USA)
2:15 PM - 2:45 PM
Lateralized Atrophy and Emotions in FTD
Speaker: Virginia Sturm (USA)
2:45 PM - 3:15 PM
Redefining the ALS-FTD Spectrum: Biological & Clinical Considerations
Speaker: Michael Strong (Canada)
3:15 PM - 3:45 PM

Coffee Break
3:45 PM - 5:15 PM

Abstracts Session 1.1 - Behaviour/Cognition/Language
3:45 PM - 5:15 PM

Abstracts Session 1.2 - Neuropathology
5:15 PM - 7:00 PM

Poster Viewing & Welcome Reception
Friday, October 9, 2026
7:30 AM - 8:30 AM

Industry Sponsored Breakfast Symposium
8:30 AM - 10:00 AM

Plenary Session 2 - Biomarker/Epidemiology
8:30 AM - 9:00 AM
Mapping the Exposome and Biomarker Signatures of Frontotemporal Dementia Across Latin America
Speaker: Agustin Ibañez (Chile)
9:00 AM - 9:30 AM
RNA Dysregulation and Cryptic Splicing in TDP-43 Proteinopathy as Biomarker
Speaker: Pietro Fratta (UK)
10:00 AM - 10:30 AM

Coffee Break
10:30 AM - 12:00 PM

Abstracts Session 2 - Biomarker/Imaging
12:00 PM - 1:30 PM

Lunch & Poster Viewing
12:15 PM - 1:15 PM

Industry Sponsored Lunch Symposium
1:30 PM - 3:30 PM

Plenary Session 3 - Update on Genetics and Neuropath of FTD
1:30 PM - 2:00 PM
Structural Classification of FTLD
Speaker: Benjamin Ryskeldi-Falcon (UK)
2:00 PM - 2:30 PM
Genes and Risk Factors for FTLD Subtypes
Speaker: Rosa Rademakers (Belgium)
3:30 PM - 4:00 PM

Coffee Break
4:00 PM - 4:15 PM

Introduction to The Holly Hayes Lecture on FTD
Speaker: Marsel Mesulam (USA)
4:15 PM - 4:45 PM

Holly Hayes Annual Lecture on FTD
Speaker: Susan Dickinson (USA)
4:45 PM - 5:30 PM

Panel: Recent Advances in Biomarkers and Emerging Therapies Shaping the Research Landscape
Moderator: Nicole Bjorklund (USA)
Panelists: Adam Boxer (USA), Alexander Murley (UK) & Yolande Pijnenburg (The Netherlands)
5:30 PM - 6:00 PM

ISFTD Business Meeting
Saturday, October 10, 2026
7:30 AM - 8:30 AM

Industry Sponsored Breakfast Symposium
8:30 AM - 10:00 AM

Plenary Session 4 - Clinical Trials/Trial Design
8:30 AM - 9:00 AM
Digital Health Assessments in FTLD
Speaker: Adam Staffaroni (USA)
9:00 AM - 9:30 AM
Update on Tau Targeting Trials in PSP/CBS
Speaker: Günter Höglinger (Germany)
9:30 AM - 10:00 AM
From Care to Clinical Trials: Centering Individuals and Families in FTD Research
Speaker: Lauren Massimo (USA)
10:00 AM - 10:30 AM

Coffee Break
10:30 AM - 12:00 PM

Abstracts Session 3.1 - Genetics
10:30 AM - 12:00 PM

Abstracts Session 3.2 - Behviour/Psychiatry
12:00 PM - 1:30 PM

Lunch & Poster Viewing
12:15 PM - 1:15 PM

Industry Sponsored Lunch Symposium
1:30 PM - 3:00 PM

Abstracts Session 4.1 - Pathomechanism
1:30 PM - 3:00 PM

Abstracts Session 4.2 - Clinical Overlap/Care management
3:00 PM - 3:30 PM

Coffee Break
3:30 PM - 5:00 PM

Plenary Session 5 - Pathomechanisms and Translation
3:30 PM - 4:00 PM
Disruption of RNA Metabolism and Emerging Therapeutic Targets
Speaker: Clotilde Lagier-Tourenne (USA)
4:00 PM - 4:30 PM
Transynaptic Tau Spread in Tauopathies
Speaker: Tara Spires-Jones (UK)
5:00 PM - 7:00 PM

ISTAART PIA Workshop: Integrating Diversity into Frontotemporal Dementia Research: From Biological Insight to Equitable Clinical Practice
Sunday, October 11, 2026
8:30 AM - 10:30 AM

Plenary Session 6 - HOT Topics
10:30 AM - 11:00 AM

Special Session & Closing Remarks